Understanding predictors of continued long-term pediatric cancer care across the region: A report from the Consortium for New England Childhood Cancer Survivors.
Jennifer J G WelchLisa B KenneyPriya HirwayG Naheed UsmaniNina S Kadan-LottickSatkiran S GrewalMary HuangHeather BradeenJeremy AderLisa DillerCindy L SchwartzPublished in: Pediatric blood & cancer (2017)
In this regional cohort, many patients who are survivors of ALL continue to participate in oncology care at 5 and 10 years from diagnosis. Factors known at diagnosis including insurance status, CNS leukemia, older age, and enrollment on therapeutic study were associated with differential attendance to follow-up visits.
Keyphrases
- end stage renal disease
- palliative care
- young adults
- affordable care act
- ejection fraction
- healthcare
- chronic kidney disease
- newly diagnosed
- health insurance
- childhood cancer
- prognostic factors
- acute myeloid leukemia
- peritoneal dialysis
- physical activity
- quality improvement
- pain management
- patient reported outcomes
- chronic pain
- early life